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SUMMARY
The process of placental separation is not completely understood. In domestic
animals, especially cattle, it is important that expulsion of the fetal membranes takes
place in a timely manner in order to achieve maximal reproductive efficiency. The
activity of the matrix-metalloprotease (MMP) family of proteases is known to be
reduced in placentomes fromcases of retained placenta.Members of theMMP family
are known to be activated by the plasminogen activator (PA) family of proteases. We
hypothesized that the expression and activity of the PA family increase in the
cotyledon and/or caruncle as parturition approaches, with maximal expression
and activity at parturition. To test this hypothesis,weperformed reverse-transcriptase
quantitative PCR and plasminogen-casein zymography to detect the presence and
activity of PA familymembers in the placentome leading up to and during parturition in
spontaneous and dexamethasone-induced parturient ewes. The results from our
experiments indicated that serine proteases inhibitor E1 (SERPINE1) mRNA abun-
dance in the cotyledon was different between treatment groups (P ¼ 0.0002). In the
caruncle, gene expression for plasminogen activator urokinase-type (PLAU) was
different (P ¼ 0.0154), and there was a strong trend for differences in SERPINE1
expression (P ¼ 0.0565). These results demonstrate that expression of the PA
system in the placentome changes from late pregnancy to parturition, and the
presence or activity of these enzymes may occur after fetal expulsion.
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INTRODUCTION
Retained placenta is a reproductive disorder of signifi-
cant concern to dairy producers as it has recently been
estimated to reduce milk production by 753 kg over the
course of a 305-day lactation period (Dubuc et al., 2011).
Aside from lost milk production, retained placenta in-
creases the risk for developing endometritis; together,
these reproductive disorders are associated with reduced
pregnancy rates (15% and 16%, respectively; Fourichon
et al., 2000). Both are associated with an increased risk of
metritis (Dubuc et al., 2010), and extend days-to-concep-
tion by 7 days (Fourichon et al., 2000). Retained placenta is
also of concern for beef producers as induction of parturi-
tion (e.g. with dexamethasone) or Cesarean sections are
known to increase the risk of the same disorder (Eiler and
Fecteau, 2007).
Placental development in ruminants is mediated by
trophoblast adhesion mainly within the placentome. Adhe-
sion of trophoblasts to endometrial cells occurs through the
action of integrins and their interaction with extracellular
matrix proteins, most notably osteopontin (Johnson
et al., 2003).Duringparturition, integrin-mediatedadhesion
must be disrupted in order to facilitate proper expulsion of
the fetal membranes, which is an important step for the
proper involution of the uterus following pregnancy. Studies
that have investigated themolecular mechanism of placen-
tome separation are limited, and have primarily focused on
the collagenolytic family of proteases. Gross et al. (1985)
were the first to report reduced collagenolytic activity in
cases of retained placenta, but subsequent studies
have produced conflicting results in terms of whether or
not collagenolytic activity is reduced (Maj and Kankofer,
1997; Walter and Boos, 2001; Dilly et al., 2011).
Collagenases, also known as matrix-metalloproteases
(MMPs), are a family of 26 Zn2þ-dependent endopro-
teases. Four inhibitors (tissue inhibitor of matrix-metallo-
proteases: TIMPs) of these proteases are known to play
roles in modulating the activities of the MMP. Each MMP
possesses a spectrum of specificities for different extracel-
lular matrix proteins with some functional overlap, the
most common being collagen (Overall, 2002). MMPs are
synthesized and secreted as inactive zymogens (pro-
MMPs). Activation involves removal of the N-terminus to
expose the catalytic Zn2þ, referred to as the cysteine switch
(Chakraborti et al., 2003). Once pro-MMPs are secreted,
it is thought that proteases within the plasminogen
activator (PA) family are responsible for MMP activation
(Ny et al., 2002; Curry and Osteen, 2003). The PA
family consists of the enzymes plasmin/plasminogen
(PLG), plasminogen activator tissue-type (PLAT), plasmin-
ogen activator urokinase-type (PLAU), and its receptor
(PLAUR). Inhibitors of thePA family includea2-antiplasmin,
plasminogen activator inhibitor-1 (SERPINE1), plasmino-
gen activator inhibitor-2 (SERPINB2), and protein C
inhibitor (SERPINA5). These inhibitors covalently bind
to their ligands, blocking activity of the enzyme, and
eventually leading to their degradation (Olson et al.,
2001).
Plasminogen is proteolytically converted to plasmin by
other proteases, most notably PLAT and PLAU (Ny
et al., 2002). Both activators are also secreted as single
polypeptide chains and possess little (PLAT) to no (PLAU)
activity in their single chain form (Mayer, 1990). When
exposed to fibrin (PLAT) or bound to their receptor
(PLAU), theseenzymesgain limited activity that is sufficient
to initiate a reciprocal activation cascadewith plasminogen/
plasmin (Lijnen et al., 1990; Higazi et al., 1995). PA-depen-
dent activation of MMPs can result in the activation of pro-
PA and other MMPs, further propagating the proteolytic
cascade (Orgel et al., 1998; Nyet al., 2002; Xu et al., 2010).
Under normal physiological conditions, the ratio between
the PA enzymes and their inhibitors favors the inhibitors.
The known role of PA in activation of MMPs, combined with
reports that placentomes from retained fetal membranes
possess reduced MMP activity, suggests that reduced PA
activity may play a role in the pathogenesis of retained
placenta in cattle. To elucidate the involvement of the PA
system in placental separation and retained placenta, we
compared PA expression and activity in placentomal tis-
sues from late gestation, in spontaneously lambing ewes,
and in ewes induced to lamb with dexamethasone. Lastly,
as tissue collection technique is more invasive than a
standard Cesarean section, we documented the impact
of Cesarean section/placentome collection on subsequent
reproductive performance.
RESULTS
Reproductive Performance of Ewes Following
Cesarean Section
Neither the number of lambs nor the sex of the lambs in
the litter were different between any of our treatments
(P ¼ 0.44 and P ¼ 0.77, respectively). None of the 13
ewes from which placentomeswere collected at parturition
died from the procedure, and no ewe experienced retained
placenta. Of these, 12 ewes were mated via live cover, and
11 were subsequently found to be pregnant (91.7%).
Reverse Transcriptase Quantitative
(Real-Time) PCR
Messenger RNA abundance in the cotyledon for PLAU,
PLAUR, andSERPINB2was not different for any treatment
group (P > 0.05, Fig. 1A,B,D). There was a treatment
effect on mRNA abundance for SERPINE1 (P ¼ 0.0002)
in cotyledonary tissue, however. Abundance of SERPINE1
mRNA in cotyledonary tissues was greatest in those ewes
treatedwith 10 mgof dexamethasonecompared toall other
treatment groups (Fig. 1C).
In the caruncle, there were no treatment effects on
mRNA abundance of PLAUR or SERPINB2 (P > 0.05;
Fig. 2B,D), but there was a treatment effect on mRNA
abundance of PLAU (P ¼ 0.015) and a strong tendency
for SERPINE1 (P ¼ 0.0565). Lastly, neither PLAT nor PLG
expression could be detected usingmultiple sets of primers
at different locations along the transcript.
SERINE PROTEASES IN THE OVINE PLACENTA
Mol. Reprod. Dev. 80:466–473 (2013) 467
Immunoblotting and Casein-Plasminogen
Zymography
Plasminogen casein zymography failed to detect PA
activity in cotyledons and caruncles at all time points
(data not shown), even though purified human PLAU activ-
ity was detectable at 24 hr of incubation to levels as low as
25 mIU. Using immunoblotting, only the positive control
(50 IU purified human urokinase-type PA) was detected.
Gelatin zymography (as described by Maj and Kankofer,
1997) of a selected number of cotyledonary and caruncular
tissue samples indicated that the samples do possess
gelatinolytic capacity, indicating that the samples were
not compromised during tissue collection or extraction
(data not shown).
DISCUSSION
While we found no differences in expression for PLAU,
PLAUR, and SERPINB2 in the cotyledon at any time point
or treatment examined, differences inmRNAabundance of
SERPINE1 were observed. Serine protease inhibitor E1
(also called plasminogen activator inhibitor-1, or PAI-1)
along with SERPINB2 (PAI-2), are the main inhibitors of
PAs (Blasi et al., 1987; Conese and Blasi, 1995). Elevated
expression of SERPINE1 during parturition is to be ex-
pected, as it is known to be regulated by dexamethasone in
vivo (Medcalf et al., 1988) and circulating concentrations of
glucocorticoids are elevated during parturition. Aside from
its ability to bind to and ablate PA activity, SERPINE1 is also
capable of regulating cell adhesion to the extracellular
matrix by obscuring the RGD integrin recognition tripeptide
found within vitronectin (Deng et al., 2001). Localized
secretion of SERPINE1 to the fetalmaternal interface
would disrupt adhesion of the cotyledon to the caruncle,
whichwouldmediate placental separation/expulsion.While
vitronectin does not appear to be distributed along the
fetal x2013;maternal interface (Burghardt et al., 2009),
osteopontin is present, though it is unknown if a similar
Figure 1. AE: Least-squares means of the relative mRNA abundance for genes of interest in
cotyledonary tissue from ewes collected 17 days before predicted parturition (17d; n ¼ 5); 10 days
before predicted parturition (10d; n ¼ 5); at spontaneous parturition (Spont.; n ¼ 5); and from ewes
induced to lambwith 10 mg (10 mgDex; n ¼ 3) and 20 mg (20 mgDex; n ¼ 5) dexamethasone. Groups
with different superscripts are significantly different (P < 0.05). F: Representative immunoblot of 80 mg
of protein from homogenates of ovine cotyledons with anti-PLAU-specific goat IgG (Lane 1: pre-stained
ladder; Lanes 26: cotyledonary tissue extracts; Lanes 7: human PLAU). Band at48 kDa is presumed
to be ovine IgG, as exclusion of a primary antibody also resulted in staining at this molecular weight.
G: Representative gelatin zymograph for gelatinase activity in 80 mg of protein from cotyledon
homogenates.
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interaction takes place between osteopontin and SER-
PINE1. Further work investigating the distribution of
SERPINE1 in the placentome and its ability to bind to
osteopontin is needed to clarify its role in placental separa-
tion in ruminants.
Differences in PLAU mRNA abundance in the caruncle
may reflect the anticipation of placental separation, in-
creased leukocyte prevalence within the placentome,
and/or extracellular matrix remodeling as part of uterine
involution following parturition. While PLAUmRNA expres-
sion was detected using reverse transcriptase quantitative
PCR, PLAU was not detected by immunoblotting or plas-
minogen-casein zymography. It is unlikely that our samples
contain meaningful PLAU activity as we were able to rou-
tinely detect the positive control down to 25 mIU (9.25 ng)
of human PLAU, and overloading of samples in the zymo-
graph (up to 360 mg of protein) also failed to detect PLAU
activity at any time point. The antibody used for immuno-
blotting has been previously demonstrated to recognize
active sheep PLAU (Colgin and Murdoch, 1997). Thus, this
discrepancy between the presence of PLAU mRNA and
PLAU protein suggests that there are additional factors
controlling translation of the transcript into protein. Micro-
RNAs are known to repress both translation and increase
mRNA decay (Huntzinger and Izaurralde, 2001). Addition-
ally, the number of ribosomes associated with a transcript
has been shown to influence the abundance of a protein
(Van Der Kelen et al., 2009). Additional experiments utiliz-
ing serial collections of placentomes over the course of
stage-three of parturition are needed to elucidate what
mechanisms are responsible for impaired translation of
PLAU. To that end, we have recently developed an inex-
pensive instrument and methodology to make these col-
lections transvaginally in cattle (McNeel et al., 2013).
We were unable to detect PA and plasmin activity at any
time point or treatment examined. Our protein data support
Figure 2. AE: Least-squares means of the relative mRNA abundance for genes of interest in
caruncular tissue from ewes collected 17 days before predicted parturition (17d; n ¼ 4); 10 days
before predicted parturition (10d; n ¼ 4); at spontaneous parturition (Spont.; n ¼ 5); and from ewes
induced to lamb with 10 mg (10 mgDex; n ¼ 3) and 20 mg (20 mg dex; n ¼ 5) dexamethasone. Groups
with different superscripts are significantly different (P < 0.05). F: Representative immunoblot of 80 mg
of protein from homogenates of ovine cotyledons stained with anti-PLAU-specific goat IgG (Lane 1:
human PLAU; Lanes 2-6: caruncular tissue extracts; Lane 7: pre-stained ladder). No specific binding for
PLAU was observed in either tissue. Band at 48 kDa is presumed to be ovine IgG, as exclusion of a
primary antibody also resulted in staining at this molecular weight.G: Representative gelatin zymograph
for gelatinase activity in 80 mg of protein from caruncle homogenates.
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observations by other investigators, who noted a lack of
differences in fibrinolysis or caseinolysis in whole tissue
minces (Gross et al., 1985). While these authors failed to
detect differences in fibrinolysis (e.g., plasmin activity in
whole placentomes), this is not the only avenue by which
the PA system can activate MMPs as PLAU is known to
directly cleave MMP-9 (Zhao et al., 2008). The presence of
MMP activity in the samples indicates that proteolytic
activity of the samples had not been compromised during
tissue collection or protein extraction.
Our observations of the PA system suggest that if
transcription of the entire PA system changes between
late gestation and parturition, as observed by other inves-
tigators (Streyl et al., 2012), these changes depend on the
fetus traversing the birth canal. An endocrine signal(s) has
been recently proposed for such an event (Kamada
et al., 2012), which appear to be secreted after fetal
expulsion; this lag may account for the variation in time
betweenexpulsion of the calf and expulsion of the placenta.
Differences between our data and that from other inves-
tigators (Streyl et al., 2012) may be due to differences in
timingof tissue collection, in cDNApreparation (oligo-dT vs.
oligo-dT and random decamers), in the mechanisms re-
sponsible for placental separation between cattle and
sheep, or in method of assessment (e.g., inherent differ-
ences betweenmicroarray and reverse transcriptase quan-
titative PCR).
While cattle and sheep share identical placental micro-
anatomy, these species differ in their placentomal gross
morphology. In the ewe, the caruncle encapsulates the
cotyledon whereas the cotyledon encapsulates the carun-
cle in the bovine. Furthermore, it is known that the mor-
phological features of adjacent placentomes from sheep
and cattle differ during the last trimester (Rici et al., 2011).
In sheep, single placentomes are distinct during the last
third of gestation, while in cattle it appears that there is
some degree of fusion between multiple adjacent placen-
tomes. This fusion appears to be exclusively of fetal origin,
as adjacent caruncles are distinctly separate (Rici
et al., 2011). The impact that these differences in placen-
tomal morphology might have on the mechanisms of pla-
centomal separation is unknown.
In conclusion, our data demonstrate that differences in
expression of PA system components during late gestation
and stage-two of parturition in the ovine placentome are of
fetal and maternal origin, but neither PLAU protein nor
activity can be detected using Western blotting or plasmin-
ogen-casein zymography. Based on changes in gene ex-
pression within the PA system between late gestation and
parturition, the molecular mechanisms regulating separa-
tion of theplacentome in theeweappear to followadifferent
time course than cattle.
MATERIALS AND METHODS
Animals
All procedures were approved by the U.S. Meat Animal
Research Center (USMARC) Institutional Animal Care and
Use Committee, and were in accordance with Federation
for Animal Science Society (FASS) guidelines for the use of
agricultural animals in research. Placentomeswere collect-
ed from23 pregnant ewes at the following five different time
points: at 17 days prior to parturition (17 days; n ¼ 5); at
10 days prior to parturition (10 days; n ¼ 5); at sponta-
neous parturition (0 days; n ¼ 5); at induced parturition
using 10 mg dexamethasone (10Dex; n ¼ 3); and at in-
duced parturition using 20 mg dexamethasone (20Dex;
n ¼ 5). Ewes induced to lambwere treated with dexameth-
asone48 hr prior to their projected lambingdate,whichwas
calculated using recorded grease harnessmarking records
and average gestational length of the flock from previous
lambing seasons.
Ewes at 17 and 10 days prior to parturition were sacri-
ficed at the USMARC abattoir after stunning with a captive
bolt followed byexsanguination. The reproductive tract was
removed from the ewe, and an incision wasmade along the
anti-mesometrial side of the uterus to expose the fetus and
associated fetalmembranes. A single, intact representative
placentome was excised, excess fetal membranes and
endometrium were trimmed, the placentome was separat-
ed into cotyledonary and caruncular components, placed
into 2.0 ml cryovials, and snap frozen in liquid nitrogen
within 15 min of stunning. Samples were stored at 808C
until RNA and protein extraction.
Ewes spontaneously lambing and those induced to lamb
with dexamethazone were observed for signs of parturition
(e.g. protrusion of the chorioallantoic membrane from the
vulva).Within 30 min of the rupture of the fetalmembranes,
a line block using 30 ml of 2% lidocaine injected subcuta-
neously was performed, an incision for a Cesarean section
was made, any remaining lambs were removed, and the
endometrium was exposed. A single representative pla-
centome was then selected, clamped at the base of the
caruncle, and excised using a scalpel. Harvested tissues
were handled and stored as described in the previous
section. Following tissue collection, normal Cesarean sec-
tion procedures for closing the uterus, muscle layer, and
skin were performed. Animals were provided with flunixin
meglumine IV (50 mg/45 kg), penicillin G IM (300 kIU/ml at
1.05 MIU/45 kg of BW), and 40 IU oxytocin immediately
following the procedure. For the 48 hr following surgery,
eweswere treated daily with penicillin G IM (150 k IU/ml at
450 k IU/45 kg of BW), followed by 1.5 ml of penicillin G
and benzathine IM (150 k IU/ml each at 1.5 ml/45 kg). All
ewes expelled their fetal membranes within 24 hr of the
procedure. Ewes and lambswere then returned to the flock
to continue the production cycle. Six months later, ewes
were pasture-bred and checked for pregnancy via ultraso-
nography 60 days following removal of the rams.
RNA Extraction and Quantification
Cotyledonary and caruncular tissues were homoge-
nized, and RNA was extracted using TRIzol (Invitrogen,
Carlsbad, CA) according to manufacturer’s instructions.
Purified RNA was suspended in autoclaved distilled water
and quantified on a Nanodrop 1000 (Thermoscientific,
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Wilmington, DE). Only sampleswith a 280/260 absorbance
greater than 1.7 were used for reverse transcription.
Reverse Transcription and Primer Design
One microgram of RNA was reverse transcribed using
the Superscript III kit (Invitrogen), according to manufac-
turer’s instructions, and cDNA was diluted to 100 ml with
autoclaved distilled water. Primers for quantitative PCR
(Table 1) were designed using PRIMER-BLAST (Rozen
and Skaletsky, 2000) with ovine sequences when available
(PLAU, PLAUR, SERPINE1, SERPINB2, GAPDH). Other-
wise, alignments of the mouse, rat, human, and bovine
sequences were used to search for regions of high homol-
ogy, with the preference given to the bovine sequence
(PLG, PLAT, SERPINA5). Intron-spanning primer pairs
were chosenbasedon the annotation of the gene of interest
in the bovine genome (Btau 4.6.1).
Relative mRNA Expression Using
Quantitative PCR
RelativegeneexpressionwasconductedusingPlatinum
Taq SYBR Green with UDG (Invitrogen), according to
manufacturer’s instructions. Briefly, 1.0 ml of cDNA was
combined with 19 ml of a master mix containing 200 nM of
each primer, 10 ml Platinum Taq master mix (400 mM
dATP, dCTP, dGTP, 800 mM TTP, 6 mM MgCl2, Hot-Start
Platinum Taq) and autoclaved distilled water. Polymerase
chain reactionswere subjected to 40 cycles of the following:
958C for 10 sec; 30 sec at an annealing temperature indi-
cated in Table 1; 10 sec at 728C.Reactionswere conducted
in a 96-well plate on a Roche Light Cycler 480 (Roche
Applied Science, Indianapolis, IN). Negative controls for
each primer pair consistently failed to generate signal.
Primer pairs generated a single peak during melting curve
analysis, and visualization of the PCR products by 2% gel
electrophoresis produced a single band at the predicted
size. Gene expression was calculated using the 2DDCt
method (Livak and Schmittgen, 2001) withGAPDH serving
as the reference gene and day 17 serving as the refer-
ence group.
Protein Extraction and Quantification
Protein was extracted from cotyledonary and caruncular
tissues as described previously (Dow et al., 2002). Briefly,
one-quarter of a cotyledon or caruncle was weighed and
homogenized in the appropriate amount of extraction buffer
(1 ml/500 mg) with a tissue homogenizer, then centrifuged
at 9,000g for 30 min at 48C. The supernatant was removed
and stored at 208C for later assay. Protein samples were
subjected to a maximum of three freezethaw cycles in
order to reduce variation in enzyme activity. Protein
concentrations were measured using the Pierce BCA kit
(Thermoscientific) in amicroplate, and read at 550 nmon a
Elx808
IU ultra microplate reader (Biotek instruments, Inc.,
Winooski, VT).
Casein-Plasminogen Zymography
Casein-plasminogen zymography was performed as
described previously (Dow et al., 2002). Briefly, 80 mg of
protein from caruncle or cotyledon and a standard curve of
high molecular weight human PLAU (American Diagnos-
tica, Stamford, CT) were loaded onto castellated 4% poly-
acrylamide gels (0.375 M Tris, 0.1% SDS, pH 8.6) cast on
top of a 10% polyacrylamide gels (0.375 M Tris, 0.1%
SDS, pH 8.6) containing 0.025% hammerstein-casein
(Sigma-Aldrich, St. Louis, MO) and 25 mU/ml bovine plas-
minogen (Sigma-Aldrich). Samples were electrophoresed
for 1 hr at 140 V in a Mini-Protean Tetra-cell (Bio-Rad,
Hercules, CA). Gels were removed from the apparatus,
the stacking gel was removed, and the running gel was
washed in fresh 2.5% Triton X-100 for 45 min to remove
SDS. Gels were then washed once in incubation buffer
(50 mM Tris, 100 mM NaCl, pH 7.6), placed in fresh incu-
bation buffer, and incubated for 17 hr at 378C. Gels were
thenwashed once in water, placed in staining solution (40%
methanol, 40% distilled H2O, 10% acetic acid, 0.025%
Coomassie Brilliant Blue) for 45 min, and destained in
staining solution without Coomassie. MMP-mediated
caseinolysis is unlikely with this assay as both the electro-
phoresis and incubation buffers lack the metal ions (Zn2þ,
Ca2þ) necessary for MMP activity.
Immunoblotting
Eightymicrogramsof cotyledonary or caruncular protein
and 10 IU of active, highmolecular weight PLAU (American
Diagnostica) were subjected to SDSPAGE as described
previously (Buhi et al., 1989), with slight modifications.
Gels were blotted onto nylon-supported nitrocellulose,
then blocked in 50 mM Tris, 1% Triton X-100, and 1 M
NaCl, pH 8.0. Membranes were incubated overnight with
polyclonal goat anti-PLAU (American Diagnostica) with
known cross-reactivity for ovine PLAU (Colgin and
Murdoch, 1997) (1:1,000 dilution in blocking buffer). The
TABLE 1. Primers Used to Determine Relative Quantification of mRNA Expression Using RT-qPCR
Gene Forward Reverse Amplicon size Tm Ref. accession #
PLAU 50-ACCATCTGCCTGCCCCCACT 50-GGGTCAGCCGCACACAGCAT 206 bp 608C 254692795
PLAUR 50-AGCGCCCACAGGTGTTCCTC 50-CCCTTGCGGGGCTGGGCGTC 248 bp 588C 254692821
SERPINE1 50-GGTCCGCGGTTTCATGCCCA 50-TACCAGGACCAGGCGCGTCA 184 bp 598C 291621639
SERPINB2 50-GGGCGCCCGGGGAAATACTG 50-GGACGCGTTGATGGCGTTGC 220 bp 598C 290795367
GAPDH 50-CCACCAACTGCTTGGCCCCC 50-GGGATGACCTTGCCCACGGC 208 bp 608C 296785214
SERINE PROTEASES IN THE OVINE PLACENTA
Mol. Reprod. Dev. 80:466–473 (2013) 471
next day, membranes were removed from the primary
antibody, washed five times, and incubated in secondary
rabbit anti-goat IgG conjugated to horseradish peroxidase
(Sigma-Aldrich) (1:10,000dilution) for 1 hr, andwashed five
times in blocking buffer and once in 0.9% NaCl. Mem-
branes were then stained with NovaRed (Vector Labs,
Burlingame, CA) according to kit instructions, using a
tenfold dilution of detection substrate. Membranes were
scanned using a Canon MX880.
Statistical Analysis
Relative gene expression was analyzed using the
MIXED procedure of SAS version 9.2 (SAS Institute,
Inc., Cary, NC), with treatment as the main effect. Differ-
ences were considered significant when P  0.05.
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